Gabapentin Capsule
Product Images NDC 72162-1532

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 72162-1532). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Image 01)

Figure 1 (Image 01)
FDA Label Image

Figure 2 (Image 02)

Figure 2 (Image 02)
This text appears to be a description of a study evaluating the effectiveness of different doses of gabapentin in reducing pain. The study was conducted over a period of 7 weeks, with participants receiving different doses of gabapentin (1800 mg/day and 2400 mg/day) or a placebo. The pain scores of the participants were measured at baseline and at 1, 2, 3, 4, 5, 6, and 7 weeks. The text includes a graph showing the mean pain scores over the course of the study.*
FDA Label Image

Figure 3 (Image 03)

Figure 3 (Image 03)
FDA Label Image

Cockcroft And Gault Equation (Image 04)

Cockcroft And Gault Equation (Image 04)
FDA Label Image

Gabapentin Structural Formula (Image 05)

Gabapentin Structural Formula (Image 05)
FDA Label Image

Image-09 (Image 09)

Image-09 (Image 09)
FDA Label Image

Label (Lbl721621532)

Label (Lbl721621532)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.